Optimizing light dosimetry in photodynamic therapy of early stage carcinomas of the esophagus using fluorescence spectroscopy
Data up to Jan 2025
Total Citations Per Year
Abstract
References (10)
HOW DOES PHOTODYNAMIC THERAPY WORK?
1992 • 2,366 citations
Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumour photosensitizers
1989 • 307 citations
Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results
1991 • 225 citations
Evaluation of a new photosensitizer, meso‐tetra‐hydroxyphenyl‐chlorin, for use in photodynamic therapy: A comparison of its photobiological properties with those of two other photosensitizers
1994 • 174 citations
Antibody-indocyanin conjugates for immunophotodetection of human squamous cell carcinoma in nude mice.
1994 • 126 citations
Effect of drug‐light interval on photodynamic therapy with meta‐tetrahydroxyphenylchlorin in malignant mesothelioma
1993 • 102 citations
Clinical pharmacokinetic studies of photofrin by fluorescence spectroscopy in the oral cavity, the esophagus, and the bronchi
1995 • 84 citations
Selectivity ofmeso-tetra(hydroxyphenyl)porphyrins and chlorins and of photofrin II in causing photodamage in tumour, skin, muscle and bladder. The comcept of cost-benefit in analysing the results
1993 • 78 citations
Clinical pharmacokinetic studies of tetra(meta‐hydroxyphenyl)chlorin in squamous cell carcinoma by fluorescence spectroscopy at 2 wavelengths
1995 • 50 citations
THE UPTAKE OF PORPHYRIN AND ZINC‐METALLOPORPHYRIN BY THE PRIMATE PROSTATE
1993 • 12 citations